Bullish potential detected for BXBEntry conditions:
(i) higher share price for ASX:BXB along with swing up of indicators such as DMI/RSI, and
(ii) observation of market reaction around the potential support/resistance line of $19.47 from the open of 18th May.
Depending on risk tolerance, the stop loss for the trade would be:
(i) below the recent swing low from 16th June ($18.46), or
(ii) below the rising 15 day EMA (currently $18.36).
Bullish potential detected for LOVEntry conditions:
(i) higher share price for ASX:LOV along with swing up of indicators such as DMI/RSI, and
(ii) observation of market reaction around the yearly VWAP (currently $23.43).
Depending on risk tolerance, the stop loss for the trade (once activated) would be:
(i) below the quarterly VWAP (currently $22.51), or
(ii) below the recent swing low from 24th June ($21.84).
Bellevue to below $0.70G'day, thanks for viewing.
So, I published an analysis a few months ago that called for a buy-zone at sub 70c for Bellevue. That didn't quite happen and I didn't end up buying. Sour grapes? No, well I was considering how they weren't very profitable, their value destructive hedge book, and also support, resistance, and Elliot wave corrections.
I have found a co-incident target for that level again and will be watching closely. If it gets there, will have to consider more whether to buy or not then as there are other competing businesses that may be more attractive such as;
- I need to top up my Northern Star holdings. They have issues, but they are resolvable and I like their huge reserves as well as their near-term growth outlook. I will buy to hold for 15-20 years.
- Ramelius. I traded them last year for a 43% profit. Knowing that they would significantly reduce production for a couple of years, I didn't want to be the "bag holder" and own a declining share. Sometime in 2027 there should be a re-energised share price as hurdles are cleared and production ramps up again. Expect to hold until they are merged or acquired (expecting M&A to pick up again). But will happily hold if they stay independent.
- Tamboran Resources. I feel they will get into the ASX 300 at the next rebalancing in Sept. That is, of course, pure speculation. But they are no minnow anymore with a AUD1.7B market cap. If I can add them to my Super Portfolio (which I can if they are added to the ASX 300) I will be happy. They had some core acreage re-valued around 1000 - 1500% due to a recent deal with INPEX and more acreage is likely to be re-valued as they drill more and prove resources. They will also commence commercial production within the next few months which will help. A lot of growth to come in my view on their road to 2 billion cubic feet of gas production per day, which is their medium to long term goal.
Thanks and good luck everyone
Is IBR ready to pump?When looking at the chart I have a noted a list of things that I am seeing for this stock.
The company financials appear to have some catalysts that are looking more positive for their future performance.
The setup on the charts has some confluency on the OBV currently, but a couple of the pull back appear to have been defended well by the sellers.
The RSI indicates that the momentum may be reversing in the short term, but the OBV is confluent with the price increasing.
The price has broken above the previous highs and is currently re-testing and looks to be holding on the support.
I'd like to see the OBV gaining over the coming days and a candle close above the recent high; if the RSI can cool off and rebuild back into taking the high again we could see this breakout and bullish market structure confirmed.
One to keep your eye on in my opinion.
at support line, returns to resistance around $3 markSupport on long term trend line from early 2025. headwinds around $3. Moves between the two. Right on support line now. Thesis dies if we hit 1.75 area. Should feel good if weekly closes above 2. 15% loss for a 50% gain is the target stop i had in mind. Cap raise was above $3. So expect some manipulation toward there if volume turns up. Gotta get everyone out of their positions .
CSL Undervalue Gem That Will ReboundCSL Limited (ASX:CSL) has long been considered one of Australia’s premier healthcare stocks, yet recent trading levels suggest it is undervalued relative to its historical benchmarks. Currently hovering around A$100, CSL is priced well below analyst fair value estimates of A$155, reflecting a discount of roughly 36%. This gap is largely due to FY26 earnings pressure, including US$5 billion in impairments tied to CSL Vifor and restructuring charges that temporarily obscure the strength of its plasma and vaccine businesses.
Historically, CSL commanded premium valuation multiples of 28–30x earnings, compared to today’s ~19x. Sector peers average closer to 36x, underscoring the discount. Importantly, CSL’s plasma-derived therapies remain resilient, supported by structural demand drivers such as ageing populations and chronic disease prevalence. The vaccine division also provides defensive earnings streams, though near-term demand fluctuations in the U.S. have weighed on sentiment.
The rebound has already begun, with shares climbing 14% from June lows. However, the decisive recovery is expected in FY27, once restructuring charges fade and margins normalize. Key catalysts include successful execution of the CSL Seqirus demerger, stabilization in plasma pricing, and renewed investor rotation into defensive healthcare amid global macro uncertainty.
Risks remain: execution missteps in restructuring, prolonged weakness in vaccine demand, or continued capital rotation into growth sectors could delay recovery. Yet, for long-term investors, CSL offers a compelling value play. Its fundamentals—market leadership in plasma therapies, strong R&D pipeline, and defensive healthcare positioning—remain intact.
Bottom line: CSL is undervalued today, with the rebound underway but full recovery likely around FY27. Patient investors may find this an attractive entry point into a high-quality healthcare stock poised to regain its premium valuation multiples.
GMG Possible strong up trend or sharp down trend toward the 26 mKey points :
HH HL across 3 time frames ( 1hr – 4hr – daily )
Half cup formation and breakout
WMA 50 – SMA 50 BELOW PRICE
SAM 50 CROSS SMA200 JUST BLEO THE BRAKOUT POINT
No noticeable volume increase
I wouldn’t put an entry yes as imbalance have been 99% filled above price
But below there are 9% of imbalance zones and open gap not filled which if there is a sharp pull back. it is possible the we can see price go towards the 26.00 marks.
$AWC breaking out Good consolidation period and now making a clear breakout. Significant underperformer compared to $AA .
ALong
Golden Cross Loading?Price has reclaimed every major EMA and continues to print higher highs and higher lows.
The 50 EMA is now on the verge of crossing above the 200 EMA while Relative Strength vs SPY continues to improve.
With price holding above all key moving averages, the trend appears to be shifting from recovery to expansion.
Key observations:
• Price above 10, 21, 50 and 200 EMAs
• 50 EMA approaching a Golden Cross with the 200 EMA
• Relative Strength making new highs
• Buyers remain in control while structure stays intact
The next phase could come if the Golden Cross confirms and price continues building above the recent breakout zone.
Spring Setup Forming?AVG is starting to look interesting here. It’s still a highly speculative play, but the structure is improving and the chart is showing early signs of a potential move out of the current range.
Price broke down from the larger range back in April 2025. Since then, the market has essentially moved sideways with no real trend. Last month we saw a sharp pullback that may have formed a spring on the local range. This spring occurred on much lower volume compared to the Selling Climax (SC), which suggests the market may not require a deep retest of that level.
On the weekly chart, price has now pulled back into the local 50% retracement, and volume has been declining during this pullback. That combination often signals that selling pressure is fading and the market may be preparing for the next leg higher.
Targets
First target: EQ of the range
Second target: Range highs if momentum continues
Stop‑Loss
Initial SL can be placed below the spring low
If price breaks upward, the SL can be trailed higher since the broader trend is still technically bearish and we want to protect gains
Overall, this remains a speculative setup, but the structure is tightening and the risk‑to‑reward is becoming more favorable if the spring holds and buyers step in.
Potential outside week and bearish potential for DGTEntry conditions:
(i) lower share price for ASX:DGT below the level of the potential outside week noted on 9th June (i.e.: below the level of $2.38).
Stop loss for the trade would be:
(i) above the high of the outside week on 12th June (i.e.: above $2.70), should the trade activate.
Potential outside week and bearish potential for TLXEntry conditions:
(i) lower share price for ASX:TLX below the level of the potential outside week noted on 22nd May (i.e.: below the level of $13.23).
Stop loss for the trade would be:
(i) above the high of the outside week on 18th May (i.e.: above $15.09), should the trade activate.
Potential outside week and bullish potential for WOREntry conditions:
(i) higher share price for ASX:WOR above the level of the potential outside week noted on 15th May (i.e.: above the level of $12.58).
Stop loss for the trade would be:
(i) below the low of the outside week on 13th May (i.e.: below $11.79), should the trade activate.
Bullish potential detected for PLSEntry conditions:
(i) higher share price for ASX:PLS along with swing up of indicators such as DMI/RSI.
Depending on risk tolerance, the stop loss for the trade would be:
(i) below the quarterly VWAP (currently $6.09), or
(ii) below the rising 50 day MA on the daily chart (currently $5.73).
Potential outside week and bullish potential for CBOEntry conditions:
(i) higher share price for ASX:CBO above the level of the potential outside week noted on 15th May (i.e.: above the level of $4.18).
Stop loss for the trade would be:
(i) below the low of the outside week on 13th May (i.e.: below $3.63), should the trade activate.
Reversal Incoming AVA is shaping up as one to watch.
The November low may have formed a high‑volume spring with a brief throw‑under of the wedge structure. It’s a constructive signal, but confirmation is still lacking. Price has yet to break back into the range and close convincingly.
For the bullish scenario, the key level is the new yearly pivot at $0.083.
Importance of this zone: it’s the first approach into the yearly pivot, it aligns with range‑low resistance, and it intersects the downward resistance trendline. A clean, impulsive break on increased volume and close above this cluster would signal real strength.
If that breakout occurs, the next expectation is a pullback to retest the spring, especially given the spring printed higher volume than the selling climax, making it a logical demand check.
Scenario 2
Since price is in high-risk zone a strong rejection here could result in a much deeper pullback. First zone of interest would be the yearly 1 pivot
PYC Ready for a bullish momentum I have been following PYC for a whale, I believe the that we are going to see another bullish momentum.
Below the 0.920 there aren’t imbalance zones, everything up the 24 of sept has been retested.
But after this point you will notice liquidity still no swept and several imbalance zones. The market structure shows HH Hl across Daily- 4hrs – 1hrs time frame which confirm that it is still on a bullish momentum.
The triangle pattern tells us that the price is going towards the liquidity and possible below to touch the next down IMB /order blocks before the reversal.
In conclusion I believe we a going to see another up trend, considering the latest news on the progress that has been made across the clinical pipeline is positive.
This is my second post, so please fill free to correct me ( I am new on this game)
Appreciate any comments and thank you for reading my post.
GT
Potential outside week and bullish potential for IGOEntry conditions:
(i) higher share price for ASX:IGO above the level of the potential outside week noted on 22nd May (i.e.: above the level of $9.27).
Stop loss for the trade would be:
(i) below the low of the outside week on 19th May (i.e.: below $8.00), should the trade activate.






















